TVARDI THERAPEUTICS, INC. (TVRD) Operating cash flow 2016–2025
TVARDI THERAPEUTICS, INC. (TVRD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.5MFY2025 · since FY2016: -$47.4M → -$23.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.5M | -28.4% |
| FY2024 | -$18.3M | +80.1% |
| FY2023 | -$92.1M | -17.0% |
| FY2022 | -$78.7M | -31.0% |
| FY2021 | -$60.1M | -995.1% |
| FY2020 | -$5.5M | +95.0% |
| FY2019 | -$109.2M | -389.8% |
| FY2018 | -$22.3M | +59.3% |
| FY2017 | -$54.8M | -15.7% |
| FY2016 | -$47.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice